Norovirus infections in preterm infants: wide variety of clinical courses by Armbrust, Sven et al.
BioMed  Central
Page 1 of 6
(page number not for citation purposes)
BMC Research Notes
Open Access Short Report
Norovirus infections in preterm infants: wide variety of clinical 
courses
Sven Armbrust1, Axel Kramer2, Dirk Olbertz3, Kathrin Zimmermann4 and 
Christoph Fusch*1
Address: 1Department of Neonatology, University-Children's Hospital, 17475 Greifswald, Germany, 2Institute for Hygiene and Environmental 
Medicine, Ernst Moritz Arndt University Greifswald, 17475 Greifswald, Germany, 3Department of Neonatology, Suedstadt Clinic, 18059 Rostock, 
Germany and 4Friedrich Loeffler Institute for Medical Microbiology, Ernst Moritz Arndt University Greifswald, 17475 Greifswald, Germany
Email: Sven Armbrust - sven.armbrust@web.de; Axel Kramer - kramer@uni-greifswald.de; Dirk Olbertz - dirk.olbertz@kliniksued-rostock.de; 
Kathrin Zimmermann - kazimmer@uni-greifswald.de; Christoph Fusch* - fusch@mcmaster.ca
* Corresponding author    
Abstract
Background: Norovirus is an important cause of nonbacterial acute gastroenteritis in all ages.
Atypical courses are described. Clinical symptoms are diarrhea, vomiting, nausea, abdominal
cramps, fever and malaise. Apart from three recent short reports we describe for the first time an
outbreak of norovirus in a tertiary Neonatal Intensive Care Unit.
Findings: The typical symptoms of norovirus infection are in part also seen in premature born
infants but with a different pattern and a huge variety of clinical courses. Vomiting is not the main
symptom of norovirus infection in premature infants but distended abdomen and other symptoms
such as apnea, gastric remainders or sepsis like appearance. The course in premature born patients
could be explained by an immunocompromised mice model. Extensive hygienic measures were
necessary to control the outbreak without closing the Neonatal Intensive Care Unit.
Conclusion: Norovirus infection in premature infants shows an impressive pattern of a wide
variety of clinical courses. Only the consequent use of different hygienic pattern can lead to
elimination of norovirus.
Background
Norovirus, belonging to the family of Caliciviridae, is a
highly contagious virus and has been found to be one of
the most important causes of nonbacterial acute gastroen-
teritis in all ages in developing as well as in developed
countries [1-3]. While most of the outbreaks are known to
have a seasonal pattern, sporadic cases of disease through-
out the year are described [4,5]. Although outbreaks can
occur in a variety of settings, semiclosed communities like
hospitals are favoured [6]. Norovirus are transmitted
through common sources such as food and water, person-
to-person contact or airborne via aerosolized vomit
whereas an extremely small dose of virus patricles (3 – 10)
already can lead to infection [7-9]. Norovirus can be
detected by ELISA as in this report, by RT-PCR or electron
microscopy.
A lot of reports and studies about norovirus and its out-
breaks exist covering a wide range of different areas and
age groups with the few, typical clinical symptoms. Atypi-
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cal courses of the disease are described in immunocom-
promised patients and persons under severe stress
[10,11].
Cause of this outbreak was a mother of a hospitalised pre-
term baby. She suffered from typical clinical signs of noro-
virus infection including acute diarrheal illness and was
tested positive for norovirus shortly before the onset of
clinical symptoms in our patients.
Apart from three recent reports dealing with norovirus
outbreaks in premature infants we describe for the first
time an outbreak of norovirus infections, its clinical
course and control with extensive hygienic measures in a
tertiary Neonatal Intensive Care Unit (NICU) affecting 11
infants over a period of two months showing an impres-
sive pattern of a wide variety of clinical courses [12,13].
Case Report
Case 1
26 weeks of gestation, 760 g, on nasal CPAP, on day 14
acute severe worsening of the general condition, anemia,
increasing oxygen demand, sepsis-like clinical appearance
with increasing apnea followed by intubation and ventila-
tion for 7 days, proof of norovirus for three weeks also in
tracheal aspirate.
Case 2
26 weeks of gestation, 820 g, initial clinical course with-
out complications, on day 34 sudden development of
tachycardia, restlessness, distended abdomen and worsen-
ing of general condition, sepsis-like clinical appearance
with tachypnea, thrombocytopenia and anemia, increas-
ing oxygen demand. Proof of norovirus, later also rota-
and astrovirus. Child developed necrotizing enterocolitis
2B° and underwent surgery with left sided hemicolec-
tomy and ileostoma.
Case 3
29 weeks of gestation, 1150 g, on day 5 acute worsening
of the general condition, increasing gastric remainders,
vomiting, distended abdomen, proof of norovirus.
Case 4
25 weeks of gestation, 740 g, increasing oxygen demand,
recurrent severe apnea with bradycardia parallel to the
detection of norovirus. Recurrent severe infection during
a two month period with constant proof of norovirus
shedding. No abdominal symptoms.
Case 5
32 weeks of gestation,
1. twin, 990 g, distended abdomen, on day 21 vomiting
and distended abdomen, parenteral nutrition, proof of
norovirus
2. twin, 1900 g, distended abdomen, greenish – mucous
stool with visible blood, norovirus suspected but not
surely proven
Case 6
29 weeks of gestation, 1170 g, distended abdomen, proof
of norovirus
Case 7
32 weeks of gestation,
1. triplet, 1780 g, on day 7 vomiting and distended abdo-
men for five days, proof of norovirus.
2. triplet, 1260 g, on day 8 acute worsening of the general
condition, green gastric remainder, increasing oxygen
demand, increasing apnea and respiratory insufficiency,
then mucous stool with visible blood followed by colitis
and coecostomy, capillary leak and multi organ failure,
death on day 14. Norovirus not surely proven but proof of
rotavirus
3. triplet, 1480 g, on day 11 slight worsening of the gen-
eral condition with pale marble like skin colour, gastric
remainder, distended abdomen, stool with visible blood,
no proof of norovirus.
Case 8
29 weeks of gestation, 1220 g, on day 4 slight gastric
remainder with fresh blood, proof of norovirus infection
All different clinical symptoms are summarized in table 1:
Discussion
Norovirus has not been proven in all our patients but
according to the case categories of the German Federal
Health Office (Robert – Koch – Institute, Berlin, Ger-
many) norovirus infection can be assumed in an outbreak
with similar clinical courses, proof of norovirus and/or
with an epidemiological connection [14]. Other similar
definitions have been also used in defining norovirus out-
break [15,16]. Also the given sensitivity and specificity of
ELISA tests can lead to negative results despite the pres-
ence of norovirus [17]. The test used at our laboratory was
a commercial ELISA test kit (Ridascreen Norwalk like
virus, R-Biopharm, Darmstadt, Germany) [18].
Two recent studies question the validity of enzyme immu-
noassays (ELISA) in norovirus infection and request RT-
PCR instead [12,13]. It seems true that the currently avail-
able methods vary greatly in sensitivity, specificity andBMC Research Notes 2009, 2:96 http://www.biomedcentral.com/1756-0500/2/96
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scope for the detection of norovirus [17]. RT-PCR was not
available in our study but in a study by Duizer et al. the
sensitivity using ELISA increases with sufficient positive
samples [19]. In another study by Rabenau et al. which
compared ELISA, PCR and transmission electron micros-
copy it was shown that all three methods are useful [20].
The discrepancies seen can be explained by the different
components each method detects. Even though PCR has
the highest sensitivity a negative PCR would not necessar-
ily exclude norovirus infection. Having a source with
proven norovirus infection plus the typical clinical course
in a mother of one of our hospitalised preterm babies and
eight positive samples plus a much better sensitivity in our
test kit we therefore see the results of our ELISA being suf-
ficient to confirm norovirus outbreak in our patients.
General clinical symptoms of norovirus infection are
described as diarrhea, vomiting, nausea, abdominal
cramps, fever and malaise, whereas vomiting occurs more
frequently in children and diarrhea more typically in
adults [14]. The disease typically lasts one to four days, is
self-limited and does not cause chronic infection. Shed-
ding of human calicivirus can last for two weeks and
younger children tend to shed for a longer period than
older children [21]. Viruses can be detected in stool spec-
imens of some children for a longer period without any
signs for illness [22].
Looking at the wide variety of clinical courses in our
patients it becomes clear that gastrointestinal problems
are the leading symptoms also in neonates (81.8%).
Table 1: Clinical symptoms of all cases
Case 1 Case 2 Case 3 Case 4 Case 5.1 Case 5.2 Case 6 Case 7.1 Case 7.2 Case 7.3 Case 8
Respiratory insufficiency X X
Apnea/Tachypnea X X X X
Additional oxygen X X X X
Sepsis like X X
Anemia X X
Thrombocytopenia X
Tachycardia X
Gastric Remainders X X X X
Distended Abdomen X X X X X X X
NEC/colitis X X
Vomiting X X X
Recurrent severe infections X
Blood stool X X X
Blood in Gastric Remainders X
Skin colour X
Death X
Proof of Virus
In stool X X X X X (?) X X (?) X
In tracheal aspirate X XBMC Research Notes 2009, 2:96 http://www.biomedcentral.com/1756-0500/2/96
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According to Kaplan et al. one should always consider
norovirus infection in case of explosive vomiting in more
than 50% of the patients, acute diarrhea for a period of 12
to 60 hours with an incubation period of 6 to 48 hours
[23]. Given these criteria vomiting occurred in only 27%
of our patients whereas 63% suffered from distended
abdomen. None of our patients suffered from acute
diarrhea and apart from abdominal distension only one
third showed signs of a lower gastrointestinal tract
involvement. A very recent study by Turcios-Ruiz et al.
described an outbreak of necrotizing enterocolitis caused
by norovirus especially in small premature infants which
supports our observation in case 2 and our assumption
that case 7.2 suffered also from norovirus infection
although the norovirus infection has not been confirmed
in this case [24].
During the outbreak all patients of the NICU received a
regular screening for norovirus. We found no asympto-
matic carriers in our patients.
In general pulmonary symptoms are often the first non
specific sign for infection in premature born infants but
interestingly these last longer in patients with norovirus
infection. Given the immaturity of the immune system of
the premature born organism it is surprising that in one
case we nearly did not see any signs for infection whereas
it is known that the susceptibility of human to norovirus
infection is determined by allelic variation in human
histo-blood group antigens (HBGA) as described by
Huang and others [25]. Proof of norovirus in tracheal
aspirate has not been described before (case 1 and 2) and
was done in our cases as we initially could not explain the
high increase of oxygen demand. Apart from a direct infec-
tion of respiratory mucosal cells it might be possible that
external contamination could have led to a contamina-
tion of respiratory secretions and also microaspiration.
Currently norovirus is divided into 7 genogroups with
more than 40 genetic clusters but many aspects of norovi-
rus biology are not well understood [26]. The murine
norovirus model system provides the first opportunity to
understand the mechanism and pathogenesis of the infec-
tion [27]. In this mouse model Karst et al. were able to
show that severely immunocompromised mice lacking
the signal tranducer and activator of transcription 1
(STAT1) had high levels of virus RNA in all organs exam-
ined. Also these mice had histopathological signs of pneu-
monia and loss of splenic architecture and severe liver
inflammation after oral inoculation [27]. Seeing the pre-
mature infant as a "naturally" immunocompromised
patient this observation might explain the wide variety of
clinical courses.
One might only speculate whether a prolonged virus
shedding and so related immune reaction may lead to a
higher susceptibility to bacterial infection in premature
born infants as seen in case 4 or whether it is only expres-
sion of an immunocompromised situation with an
extended time for recovery.
A couple of problems are pathognomonic for NICUs
worldwide: there is rarely a larger space between the incu-
bators. The opening of a heated incubator is similar to an
overpressurized chamber and will inevitabely lead to an
airborne spread of particles. The frequent visit from par-
ents and relatives and even smaller infants are highly sup-
ported to strengthen the bonding between the preterm
infant and its family. This all can lead to a persistent and
circulating infection especially in a semi-closed commu-
nity as described earlier [6].
Therefore only the consequent use of different hygienic
pattern can lead to elimination of norovirus in such a set-
ting. In our case it was wearing single use coats, gloves and
surgical face mask whenever a patient was handled and
increased use of norovirus active disinfectants as hand dis-
infection and on the ward (wiping of floor and surfaces
especially around incubators). At the beginning we used a
hand disinfectant which was recommend as highly effec-
tive on enveloped and non-enveloped viruses although
not specifically tested against feline calicivirus (surrogate
virus for norovirus) according to the Robert – Koch –
Institute [28]. Its pharmaceutically active ingredients con-
tain Ethanol 95.0 g (on 100 g, Sterillium Virugard™, Bode
Hamburg/Germany). As we could not stop the outbreak
herewith we changed to a new, ethanol reduced hand dis-
infectant: Manorapid Synergy™ (Antiseptica, Pulheim/
Germany). Its pharmaceutically active ingredients contain
10 g 1-Propanol, 57,6 g Ethanol 96% with 0,7% phos-
phoric acid (on 100 g). This disinfectant produced a log10
reduction factor of 2.38 in testing against feline calicivirus
compared to other disinfectants with increased ethanol
content [29]. For floor disinfection Perform™ 1% (Schülke
& Mayr, Norderstedt/Germany) was used which is an
active oxygen based highly effective disinfectant contain-
ing 45 g Pentakalium bis(peroxymonosulfate)bis(sulfate)
and has been tested as being effective against feline calici-
virus.
All symptomatic patients underwent strict cohortation
and care by dedicated nurses, who were not allowed to
care for other patients and to leave that area during work.
Relatives were not allowed to get into personal contact
with their babies or to peform "kangarooing" as long as
we could prove shedding of virus.BMC Research Notes 2009, 2:96 http://www.biomedcentral.com/1756-0500/2/96
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With this hygienic management we were able to limit the
disease and completely terminate it after two months
(case 4).
Finally, although not in our case, it can be necessary to
close a ward completely until the virus is eradicated. This
"worst case scenario" leads to a loss of proceeds which was
calculated by Lopman et al. as 1,01 million $ per 1000
hospitals beds [30].
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